
Journal of Organometallic Chemistry p. 141 - 156 (1985)
Update date:2022-08-03
Topics:
Hofmann, L.
Werner, H.
The cyclopentadienylcobalt(I) compounds C5H5Co(PMe3)P(OR)3 (R=Me, Et, Pri) and C5H5Co(C2H4)L (L=PMe3, P(OMe)3, CO) are prepared by ligand substitution starting from C5H5Co(PMe3)2 and C5H5Co(C2H4)2.Whereas the reaction of C5H5Co(PMe3)P(OMe)3 with CH2Br2 mainly gives a mixture of C5H5CoCH2Cl(PMe3)I and C5H5CoCl(PMe3)I, which can be separated due to their different solubilities.The same reaction in the presence of ligand L gives the carbenoidcobalt(III) compounds
Shanghai Dano Pharmaceutical Co.,Ld.(expird)
Contact:+86-592-6266840
Address:Building 1 Room 512, 720 Cailun Rd, Zhangjiang High-Tech Park, Shanghai 201203, China
BrightGene Bio-Medical Technology Co., Ltd.
website:https://en.bright-gene.com/
Contact:+86-512-62551801
Address:Building C25 - C31, No. 218 Xinghu Road, Suzhou Industrial Park, Suzhou, Jiangsu, China.
Chengdu Shengnuo Biological Technology Co., Ltd.
Contact:86-028-85275045
Address:Sichuan Province Chengdu hi tech Zone Tianfu Avenue North of 1480
Taizhou Chemedir Biopharm-tech Co., Ltd
Contact:+86 523 86200218
Address:G09, No. 1 Avenue China Medical City, Taizhou,Jiangsu, China
Doi:10.1055/s-2007-986664
(2007)Doi:10.1002/ejic.200600620
(2006)Doi:10.1002/anie.201407806
(2014)Doi:10.1039/f19858102191
(1985)Doi:10.1021/ol701925a
(2007)Doi:10.1021/ja01535a029
(1958)